Celularity
CELU
35 hedge funds and large institutions have $195M invested in Celularity in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 8 closing their positions.
75% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 8
29% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 7
25% more capital invested
Capital invested by funds: $156M → $195M (+$38.9M)
21% more funds holding
Funds holding: 29 → 35 (+6)
1.46% more ownership
Funds ownership: 5.43% → 6.89% (+1.5%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$23.3M |
| 2 |
GCL
Glazer Capital LLC
New York
|
+$17.9M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$12.9M |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$9.35M |
| 5 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
+$8.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
-$23.3M |
| 2 |
RIA
RP Investment Advisors
Toronto,
Ontario, Canada
|
-$16.4M |
| 3 |
OCAM
Owl Creek Asset Management
New York
|
-$5.87M |
| 4 |
CAC
Cowen and Company
New York
|
-$4.43M |
| 5 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
-$4.41M |
CELU Hedge Fund Activity: Q1 2020 in Review
35 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q1 2020, worth a combined $195M — up 25% from $156M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new CELU positions and 8 closed out — a net gain of 6 holders — while 9 added to existing stakes and 7 trimmed.
The largest buyer was Bank of Montreal, opening a new position worth an estimated $23.3M. The largest seller was Linden Advisors, cutting an estimated $23.3M.
- 35 institutional investors held Celularity (CELU) as of Q1 2020, up from 29 in Q4 2019.
- Funds reported $195M of Celularity stock for Q1 2020, up 25% quarter-over-quarter.
- 14 funds opened new Celularity positions in Q1 2020 and 8 closed out, a net change of +6 holders.
- The largest Celularity buyer in Q1 2020 was Bank of Montreal, an estimated $23.3M added.
- The largest Celularity seller in Q1 2020 was Linden Advisors, an estimated $23.3M sold.
Based on aggregated 13F filings for Q1 2020.